JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Hnatowich, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.-M.
Right arrow Articles by Hnatowich, D. J.
Journal of Nuclear Medicine Vol. 42 No. 11 1660-1669
© 2001 by Society of Nuclear Medicine


Basic Science Investigations

In Vitro Investigations of Tumor Targeting with 99mTc-Labeled Antisense DNA

Yu-Min Zhang, Yi Wang, Ning Liu, Zhi-Hong Zhu, Mary Rusckowski and Donald J. Hnatowich

Division of Nuclear Medicine, Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts

One objective of this investigation was to determine whether chemical modifications of oligonucleotides to permit radiolabeling with {gamma}- or positron emitters interferes with hybridization and target cell accumulation. A second objective was to establish to a reasonable extent whether cellular accumulation of radiolabeled oligonucleotides can be explained by an antisense mechanism. Methods: An 18mer uniform phosphorothioate DNA antisense to the messenger RNA (mRNA) of the type I regulatory subunit {alpha} of cyclic adenosine monophosphate-dependent protein kinase A (RI{alpha}) was conjugated with the N-hydroxysuccinimidyl derivative of S-acetylmercaptoacetyltriglycine (MAG3) through a primary amine/linker and investigated in vitro in cell culture. Results: By surface plasmon resonance, the association kinetics between native (i.e., without amine/linker) DNA and MAG3-amide/linker-DNA were identical. Melting temperatures were also identical for native DNA, amine/linker-DNA, and MAG3-amide/linker-DNA, indicating that these chemical modifications had no detectable influence on hybridization. However, cellular accumulation of 99mTc-MAG3-DNA was lower than that of 35S-MAG3-DNA, suggesting that chemical modifications can have an important influence on cellular accumulation. In tissue culture studies of ACHN tumor cells (a human renal adenocarcinoma cell type), an antisense effect was suggested by 3 findings: an increased accumulation of 35S- or 99mTc-labeled antisense versus sense DNA, an increased accumulation of 99mTc-antisense DNA in another RI{alpha}-positive tumor cell line (LS174T) but not in a murine transfected control cell line (HC-2), and the disappearance of the increased cellular accumulation of 99mTc-antisense DNA with increasing dosage of antisense DNA. Higher than expected cellular accumulations of about 105 antisense DNAs per cell over 24 h suggest stabilization of the target mRNA or increased mRNA production by the presence of the antisense DNA. In support of this suggestion, we observed, first, an increased incorporation of uridine-5'-triphosphate into RNA in cells exposed to the antisense DNA but not to the control DNA and, second, an increase in target mRNA expression in cells exposed to the antisense DNA but not to the control DNA. Conclusion: This evidence suggests tumor cell accumulation by an antisense mechanism. Moreover, the high level of DNA accumulation suggests that a rapid target mRNA turnover or transcription rate may be an important determinant of tumor counting rates.

Key Words: antisense • 99mTc • tissue culture




This article has been cited by other articles:


Home page
JNMHome page
M. Liu, R. F. Wang, C. L. Zhang, P. Yan, M. M. Yu, L. J. Di, H. J. Liu, and F. Q. Guo
Noninvasive Imaging of Human Telomerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTc-Radiolabeled Antisense Probes in Malignant Tumors
J. Nucl. Med., December 1, 2007; 48(12): 2028 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. H. Liu, Y. R. Kim, J. Q. Ren, F. Eichler, B. R. Rosen, and P. K. Liu
Imaging Cerebral Gene Transcripts in Live Animals
J. Neurosci., January 17, 2007; 27(3): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
X. Liu, K. Nakamura, Y. Wang, Y. Wang, G. Liu, J. He, H. Ding, P. Lu, M. Rusckowski, A. Kubo, et al.
Initial Mechanistic Studies of Antisense Targeting in Cells
J. Nucl. Med., February 1, 2006; 47(2): 360 - 368.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Nakamura, A. Kubo, and D. J. Hnatowich
Antisense Targeting of P-Glycoprotein Expression in Tissue Culture
J. Nucl. Med., March 1, 2005; 46(3): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B Tavitian
In vivo imaging with oligonucleotides for diagnosis and drug development
Gut, June 1, 2003; 52(90004): iv40 - 47.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J.-L. C. Urbain
Sense, Antisense, and Common Sense
J. Nucl. Med., November 1, 2001; 42(11): 1670 - 1672.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.